secwatch.observer — SEC 8-K summary
======================================

Issuer:     Denali Therapeutics Inc. (DNLI)
CIK:        0001714899
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001714899-23-000079
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Therapeutics annual meeting results: directors elected, auditor ratified
-------------------------------------------------------------------------------

- Electors voted to re-elect three Class III directors: Jennifer Cook, David Schenkein, and Ryan J. Watts.
- Ernst & Young LLP ratified as independent auditor for FY 2023 with 112,694,203 votes for.
- Advisory vote on executive compensation approved with 98,002,580 votes for.
- 82.58% of outstanding shares (112,922,471) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1714899/000171489923000079/0001714899-23-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1714899/000171489923000079/dnli-20230601.htm
  HTML page:      https://secwatch.observer/filing/0001714899-23-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer